Alumis (ALMS) Cash from Operations (2023 - 2025)
Alumis' (ALMS) quarterly Cash from Operations came in at 71884000.0 in Q4 2025, up 3.85% year-on-year from 69217652.05 in Q4 2024, and up 35.19% on a QoQ basis from 110916000.0 in Q3 2025.
Alumis (ALMS) Cash from Operations (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Cash from Operations data on file, last reported at 71884000.0 in Q4 2025.
- On a quarterly basis, Cash from Operations rose 3.85% year-over-year to 71884000.0 in Q4 2025; TTM through Dec 2025 was 369500000.0, a 44.86% decrease from a year earlier, with the FY2025 full-year figure at 369500000.0, down 44.86% from the prior year.
- Cash from Operations for Q4 2025 stood at 71884000.0, up from 110916000.0 in the prior quarter.
- Over the last five years, Cash from Operations for ALMS reached as high as 33198000.0 in Q3 2023 and fell as low as 110916000.0 in Q3 2025.
- Historically, Cash from Operations has averaged 69157600.0 across 3 years, with a median of 73324000.0 in 2024.
- Across the five-year window, Cash from Operations slumped 152.32% in 2024 and increased 3.85% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 33800000.0 in 2023, then tumbled by 121.2% to 74764000.0 in 2024, then gained by 3.85% to 71884000.0 in 2025.
- Per Business Quant data, the three most recent Cash from Operations figures were 71884000.0 in Q4 2025, 110916000.0 in Q3 2025, and 106300000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | -71.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -71.88 Mn |
| Dec 31, 2025 | -71.88 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Jun 30, 2025 | -106.30 Mn |
| Jun 30, 2025 | -106.30 Mn |
| Mar 31, 2025 | -80.40 Mn |
| Mar 31, 2025 | -80.40 Mn |
| Dec 31, 2024 | -74.76 Mn |
| Dec 31, 2024 | -74.76 Mn |
| Sep 30, 2024 | -83.77 Mn |
| Sep 30, 2024 | -83.77 Mn |
| Jun 30, 2024 | -52.25 Mn |
| Jun 30, 2024 | -52.25 Mn |
| Mar 31, 2024 | -44.30 Mn |
| Mar 31, 2024 | -44.30 Mn |
| Dec 31, 2023 | -33.80 Mn |
| Dec 31, 2023 | -33.80 Mn |
| Sep 30, 2023 | -33.20 Mn |
| Sep 30, 2023 | -33.20 Mn |